Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation.
Sleep disturbances are associated with a greater risk of serious adverse health events, economic consequences, and, most importantly, increased all-cause mortality. Several studies support the associations among sleep, immune function, and inflammation. The relationship between sleep disturbances and inflammatory conditions is complex and not completely understood. Sleep deprivation can lead to increased levels of inflammatory cytokines, including interleukin (IL)-1β IL-6, tumor necrosis factor-α and C-reactive protein, which can lead to further activation of the inflammatory cascade. The relevance of sleep in inflammatory bowel disease (IBD), a chronic immune-mediated inflammatory disease of the gastrointestinal tract, has recently received more attention. Several studies have shown that patients with both inactive and active IBD have self-reported sleep disturbances. Here, we present a concise review of sleep and its association with the immune system and the process of inflammation. We discuss the studies that have evaluated sleep in patients with IBD as well as possible treatment options for those patients with sleep disturbances. An algorithm for evaluating sleep disturbances in the IBD population is also proposed. Further research is still needed to better characterize sleep disturbances in the IBD population as well as to assess the effects of various therapeutic interventions to improve sleep quality. It is possible that the diagnosis and treatment of sleep disturbances in this population may provide an opportunity to alter disease outcomes.
Dr Kinnucan is a gastroenterology fellow and Dr Rubin is a professor of medicine and codirector of the Inflammatory Bowel Disease Center at the University of Chicago School of Medicine in Chicago, Illinois. Dr Ali is an assistant professor of medicine and the director of the OU Physicians Inflammatory Bowel Disease Center at the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma.
Jami A
JA
Kinnucan
Dr Kinnucan is a gastroenterology fellow and Dr Rubin is a professor of medicine and codirector of the Inflammatory Bowel Disease Center at the University of Chicago School of Medicine in Chicago, Illinois. Dr Ali is an assistant professor of medicine and the director of the OU Physicians Inflammatory Bowel Disease Center at the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma.
David T
DT
Rubin
Dr Kinnucan is a gastroenterology fellow and Dr Rubin is a professor of medicine and codirector of the Inflammatory Bowel Disease Center at the University of Chicago School of Medicine in Chicago, Illinois. Dr Ali is an assistant professor of medicine and the director of the OU Physicians Inflammatory Bowel Disease Center at the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma.
Tauseef
T
Ali
Crohn’s disease; Sleep; inflammation; ulcerative colitis